Kymera Therapeutics, Inc. (KYMR)

74.19 +1.10 (+1.50%) USD  |  NASDAQ  |  Jan 13, 16:00
74.19 0.00 (0.00%) After-Hours: 20:00
More

Kymera Therapeutics Net Common Equity Issued (Purchased) (Quarterly)

Net Common Equity Issued (Purchased) (Quarterly) Chart

View Net Common Equity Issued (Purchased) (Quarterly) for KYMR.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Net Common Equity Issued (Purchased) (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Net Common Equity Issued (Purchased) (Quarterly) Range, Past 5 Years

View Net Common Equity Issued (Purchased) (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Net Common Equity Issued (Purchased) (Quarterly) Benchmarks

View Net Common Equity Issued (Purchased) (Quarterly) Benchmarks
Start Trial
Regeneron Pharmaceuticals, Inc. Upgrade
Gilead Sciences, Inc. Upgrade
Cytokinetics, Inc. Upgrade
TG Therapeutics, Inc. Upgrade
Protagonist Therapeutics, Inc. Upgrade